Amphastar Pharmaceuticals: Shares Are Interesting, And Options Even More

I wrote about Amphastar Pharmaceuticals (NASDAQ: AMPH ) in February, when I estimated a Fair Value of $43.24. However, Amphastar is mostly a producer of generic drugs, without an economic moat. With a stock price of $30.75, I initiated only a very small position, and "Fundamental Options" would be the title of my investing style, because I combine fundamental analysis with the power of options. I use Fundamental Analysis to quantitatively and qualitatively assess individual stocks and ETFs, and I pursue var ...